Skip to content
Strength & muscleRandomised trial3 min read

Blood flow restriction training in stage 3 kidney disease: albuminuria rose in one small group

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Effects of muscle strength training with blood flow restriction on glomerular function in people with stage 3 chronic kidney disease. · Jornal brasileiro de nefrologia · 2026 · Original paper ↗

Key takeaway

In a 12-week trial of 40 people with stage 3 chronic kidney disease, the low-load strength training with blood flow restriction group showed a significant rise in albuminuria (p = 0.048), while creatinine and eGFR differences versus other groups were also significant in places. With 40 people split across 4 groups, the findings are preliminary and the albuminuria signal needs confirming.

Study design

Randomised trial

Reading basis

Published abstract

Reading focus

Comparator & uncertainty

The research question

Strength training combined with blood flow restriction (BFR) has shown benefit as an add-on treatment in stage 3 chronic kidney disease (CKD), but its effects on the kidneys were unclear. The authors tested how this training affects markers of glomerular (kidney filtering) function.

Who and how

Randomized longitudinal clinical trial of 40 people with stage 3 CKD in 4 groups: control (G1), low-load muscle strength training (MST, G2), high-load MST (G3) and low-load MST with BFR (G4). Serum creatinine, cystatin C, microalbuminuria and estimated glomerular filtration rate (eGFR) were the outcomes. Training ran 12 weeks, 3 times per week, 30-40 minutes, with 3 exercises per day at progressive intensities. Analysis was by intention-to-treat, using normality tests, paired t-test or Wilcoxon test within groups, ANOVA or Kruskal-Wallis between groups, Bonferroni post hoc correction and Cohen's d, with p ≤ 0.05.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Participants were 52.5% male, 60% had low physical activity, 87.5% had hypertension and 37.5% had diabetes.
  2. 2
    Group 4 (low-load training with BFR) showed a significant increase in albuminuria (p = 0.048).
  3. 3
    Group 4 differed significantly from Group 1 in creatinine (p = 0.032), and from Group 2 in creatinine (p = 0.036) and eGFR-Cr (p = 0.032).
  4. 4
    The authors conclude MST with BFR was not associated with severe adverse effects on creatinine, cystatin C, eGFR estimates, urinary creatinine or microalbuminuria, but it may significantly increase albuminuria.

Limits & uncertainty

  1. 1
    With 40 participants split into 4 groups, each arm was small, and many comparisons were made, so isolated p values near 0.05 may be chance findings.
  2. 2
    The abstract does not report group-by-group means, confidence intervals or effect sizes, so the size and direction of the creatinine and eGFR differences cannot be judged.
  3. 3
    Twelve weeks is too short to show long-term kidney outcomes, and the group was mostly people with hypertension, with some diabetes.
  4. 4
    This reading is based on the abstract only.

What to take from it

Blood flow restriction exercise is not established as safe for kidneys in stage 3 CKD: this small trial found no severe effects on most markers but a possible rise in albuminuria. Do not try restriction cuffs or new training on your own if you have kidney disease. Exercise decisions belong with your nephrologist.

Reading your own data

Wearables cannot measure creatinine, cystatin C, eGFR or albuminuria, which come from blood and urine tests. What you can track is training volume and home blood pressure, and bring your lab results trends to your clinician rather than judging from a single value.

How to read this evidence

Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Introduction

Stage 3 chronic kidney disease (CKD) represents a critical juncture in clinical management. However, muscle strength training (MST) combined with blood flow restriction (BFR) has shown benefits as an adjunctive treatment, but its renal effects remain unclear.

Objective

To analyze the effects of MST+BFR on markers of glomerular function in individuals with CKD-3.

Method

A randomized, longitudinal clinical trial with 40 participants divided into 4 groups: control (G1); low-load MST (G2); high-load MST (G3); and low-load MST combined with BFR (G4). Serum creatinine, cystatin C, microalbuminuria, and estimated eGFR were used as dependent variables. The MST protocol was conducted over 12 weeks, 3 times per week, for 30-40 minutes, with 3 exercises (single- and multi-joint) per day at progressive intensities. Data analysis (intention-to-treat) was performed using the Shapiro-Wilk test (normality), paired t-test/Wilcoxon test (within-group comparisons), ANOVA/Kruskal-Wallis tests (between-group comparisons), Bonferroni test (post hoc corrections), and Cohen's d (effect size) with a p-value ≤ 0.05.

Results

The participants were predominantly male (52.5%) with low levels of physical activity (60%), hypertension (87.5%), and some with diabetes (37.5%). Group 4 showed a significant increase in albuminuria levels (p = 0.048), as well as significant differences compared with Group 1 (creatinine, p = 0.032) and Group 2 (creatinine, p = 0.036; and eGFR-Cr, p = 0.032).

Conclusion

MST+BFR was not associated with severe adverse effects on serum creatinine/cystatin C levels, eGFR estimates, or urinary creatinine and microalbuminuria levels, but it may significantly increase albuminuria levels.

Sources & attribution

Effects of muscle strength training with blood flow restriction on glomerular function in people with stage 3 chronic kidney disease.

Caetano AFP, Oliveira JA, Silva AWD, Cabral Junior CR, Cavalcante MJO, Cirilo-Sousa MDS.

Jornal brasileiro de nefrologia · 2026-10-01

DOI: 10.1590/2175-8239-jbn-2026-0061en ↗PubMed · 42896045 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Overview of reviews

ACSM review of 137 reviews: resistance training works, and few programme details matter

The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.

Medicine & Science in Sports & Exercise

In-depth explainersRead study →
·Trial meta-analysis

Nearly every resistance training plan beat no exercise; heavy loads led for strength

In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.

British Journal of Sports Medicine

In-depth explainersRead study →
·Observational meta-analysis

Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes

Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.

British Journal of Sports Medicine

In-depth explainersRead study →
·Trial meta-analysis

Protein supplements and weight training: small extra gains, smaller in older adults

Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.

British Journal of Sports Medicine

In-depth explainersRead study →
Strength & muscle →